Anne S. De Groot

8.6k total citations
231 papers, 6.3k citations indexed

About

Anne S. De Groot is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anne S. De Groot has authored 231 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 103 papers in Immunology and 55 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anne S. De Groot's work include vaccines and immunoinformatics approaches (100 papers), Monoclonal and Polyclonal Antibodies Research (54 papers) and Immunotherapy and Immune Responses (47 papers). Anne S. De Groot is often cited by papers focused on vaccines and immunoinformatics approaches (100 papers), Monoclonal and Polyclonal Antibodies Research (54 papers) and Immunotherapy and Immune Responses (47 papers). Anne S. De Groot collaborates with scholars based in United States, Switzerland and Mali. Anne S. De Groot's co-authors include William Martin, Leonard Moise, David W. Scott, Julie A. McMurry, Frances Terry, Andrés H. Gutiérrez, Leslie P. Cousens, Rino Rappuoli, Hakima Sbai and Ryan Tassone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Anne S. De Groot

221 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne S. De Groot United States	41	3.4k	2.8k	1.9k	1.2k	1.0k	231	6.3k
Julia Ponomarenko Spain	31	4.1k 1.2×	1.7k 0.6×	1.2k 0.7×	975 0.8×	794 0.8×	74	5.5k
Jason Greenbaum United States	36	4.9k 1.5×	3.7k 1.3×	1.5k 0.8×	1.5k 1.2×	3.7k 3.5×	82	9.7k
Scott D. Gray‐Owen Canada	45	1.7k 0.5×	1.5k 0.5×	672 0.4×	1.1k 0.9×	887 0.8×	121	5.9k
Mariagrazia Pizza Italy	65	2.9k 0.9×	3.6k 1.3×	697 0.4×	5.0k 4.1×	2.3k 2.2×	246	12.0k
Margaret E. Ackerman United States	39	1.4k 0.4×	2.2k 0.8×	1.8k 1.0×	735 0.6×	978 0.9×	155	4.4k
Ted M. Ross United States	49	1.8k 0.5×	3.1k 1.1×	682 0.4×	4.4k 3.6×	2.5k 2.4×	269	8.2k
Davide Corti United States	50	1.9k 0.6×	2.0k 0.7×	1.2k 0.6×	2.3k 1.9×	5.0k 4.8×	114	8.6k
Florian Klein Germany	44	1.9k 0.6×	3.1k 1.1×	1.6k 0.9×	1.3k 1.0×	2.8k 2.7×	159	7.8k
Giampietro Corradin Switzerland	44	3.0k 0.9×	3.5k 1.2×	984 0.5×	924 0.7×	397 0.4×	164	7.4k
Lisa A. Cavacini United States	33	1.2k 0.4×	2.0k 0.7×	1.2k 0.6×	679 0.5×	1.1k 1.0×	93	4.7k

Countries citing papers authored by Anne S. De Groot

Since Specialization

Citations

This map shows the geographic impact of Anne S. De Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne S. De Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne S. De Groot more than expected).

Fields of papers citing papers by Anne S. De Groot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne S. De Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne S. De Groot. The network helps show where Anne S. De Groot may publish in the future.

Co-authorship network of co-authors of Anne S. De Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Anne S. De Groot. A scholar is included among the top collaborators of Anne S. De Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne S. De Groot. Anne S. De Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richard, Guilhem, et al.. (2024). Neoadjuvant personalized cancer vaccines: the final frontier?. Expert Review of Vaccines. 23(1). 205–212. 8 indexed citations

Haltaufderhyde, Kirk, Brian Roberts, Frances Terry, et al.. (2023). Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics. The AAPS Journal. 25(5). 87–87. 10 indexed citations

Makowski, Emily K., Jennifer M. Zupancic, Jie Huang, et al.. (2023). Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nature Biomedical Engineering. 8(1). 45–56. 21 indexed citations

Chen, Jiani, Vasanthi Avadhanula, Leonard Moise, et al.. (2023). Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus. PLoS Computational Biology. 19(1). e1010360–e1010360. 4 indexed citations

Moise, Leonard, Constantinos S. Kyriakis, Andrés H. Gutiérrez, et al.. (2022). H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans. Influenza and Other Respiratory Viruses. 17(1). e13058–e13058. 1 indexed citations

Richard, Guilhem, Michael F. Princiotta, Dominique Bridon, et al.. (2021). Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy. Expert Review of Vaccines. 21(2). 173–184. 37 indexed citations

Gutiérrez, Andrés H., Frances Terry, Bethany McGonnigal, et al.. (2021). Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. npj Vaccines. 6(1). 71–71. 29 indexed citations

Dembele, Marieme, et al.. (2020). Tregitopes improve murine asthma by promoting highly suppressive and antigen specific Tregs. Journal of Allergy and Clinical Immunology. 145(2). AB79–AB79. 2 indexed citations

Moise, Leonard, Ted M. Ross, Daniel F. Hoft, William Martin, & Anne S. De Groot. (2020). Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert Review of Vaccines. 19(9). 781–784. 1 indexed citations

10.

Scholzen, Anja, Guilhem Richard, Leonard Moise, et al.. (2019). Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever. Infection and Immunity. 87(10). 11 indexed citations

11.

Gutiérrez, Andrés H., et al.. (2019). Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi. Human Vaccines & Immunotherapeutics. 16(2). 214–227. 18 indexed citations

12.

Moise, Leonard, Bethany M. Biron, Neşe Kurt Yılmaz, et al.. (2018). T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response. Human Vaccines & Immunotherapeutics. 14(9). 2203–2207. 9 indexed citations

13.

Terry, Frances, Leonard Moise, Drew Hannaman, et al.. (2017). An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice. Human Vaccines & Immunotherapeutics. 13(12). 2824–2836. 24 indexed citations

14.

Etcheverrigaray, Marina, et al.. (2017). De-immun ized and F unctional T herapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy. Clinical Immunology. 176. 31–41. 17 indexed citations

15.

Gutiérrez, Andrés H., Vicki Rapp-Gabrielson, Frances Terry, et al.. (2017). T‐cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin. Influenza and Other Respiratory Viruses. 11(6). 531–542. 15 indexed citations

16.

Groot, Anne S. De, et al.. (2015). Barriers to Health Insurance Pre- and Post-Affordable Care Act Implementation in Providence, RI.. PubMed. 98(12). 35–9. 2 indexed citations

17.

Khalil, Eltahir Awad Gasim, Anne S. De Groot, Ahmed Musa, et al.. (2012). Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines. Human Vaccines & Immunotherapeutics. 8(12). 1769–1774. 31 indexed citations

18.

Gutiérrez, Andrés H., et al.. (2012). New vaccines needed for pathogens infecting animals and humans. Human Vaccines & Immunotherapeutics. 8(7). 971–978. 11 indexed citations

19.

Elyaman, Wassim, Samia J. Khoury, David W. Scott, & Anne S. De Groot. (2011). Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis. SHILAP Revista de lepidopterología. 2011. 1–6. 26 indexed citations

20.

Groot, Anne S. De & William Martin. (2003). From Immunome to Vaccine: Epitope Mapping and Vaccine Design Tools. Novartis Foundation symposium. 254. 57–76. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact